These tumors present the lowest mutational burden of any human tumor sequenced to date, suggesting that tumorigenesis in MRTs is induced by the epigenetic misregulation consequence of SMARCB1 loss18–21. This evidence concerns the gene SMARCB1 and neoplasm.